Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic disease targets.

The Novo Nordisk Foundation (NNF ... is the NIVI’s novel structure, combining a state-of-the-art research centre with a limited liability company, according to the NNF. That will help to ...

Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.

Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company.

Simply sign up to the European companies myFT Digest -- delivered directly to your inbox. Luxury goods maker LVMH regained its crown as the largest company in Europe on Friday, after shares in ...

It hasn't been a great period for investors in Novo Nordisk (NYSE ... illnesses like diabetes and obesity. For the company to continue to grow at the same pace it has been recently, its ...

Bernard Arnault is once again in charge of Europe's most valuable company. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...